Free Trial

908 Devices (MASS) Stock Forecast & Price Target

908 Devices logo
$2.76 +0.20 (+7.81%)
(As of 02:45 PM ET)

908 Devices - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
2

Based on 4 Wall Street analysts who have issued ratings for 908 Devices in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 2 have given a hold rating, and 2 have given a buy rating for MASS.

Consensus Price Target

$8.00
189.86% Upside
According to the 4 analysts' twelve-month price targets for 908 Devices, the average price target is $8.00. The highest price target for MASS is $14.00, while the lowest price target for MASS is $4.00. The average price target represents a forecasted upside of 189.86% from the current price of $2.76.
Get the Latest News and Ratings for MASS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for 908 Devices and its competitors.

Sign Up

MASS Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$8.00$13.00$14.00$17.00
Forecasted Upside189.86% Upside279.01% Upside240.63% Upside144.96% Upside
Consensus Rating
Moderate Buy
Buy
Buy
Buy

MASS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MASS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

908 Devices Stock vs. The Competition

Type908 DevicesMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside212.50% Upside26,931.54% Upside9.83% Upside
News Sentiment Rating
Neutral News

See Recent MASS News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/13/2024Leerink Partnrs
5 of 5 stars
P. Souda
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
11/13/2024Stifel Nicolaus
4 of 5 stars
 Lower TargetBuy ➝ Buy$17.00 ➝ $6.00+129.01%
11/13/2024Leerink Partners
1 of 5 stars
 Reiterated RatingOutperform ➝ Market Perform$12.00 ➝ $4.00+36.99%
5/13/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$14.00+112.77%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:59 PM ET.


MASS Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for 908 Devices is $8.00, with a high forecast of $14.00 and a low forecast of $4.00.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MASS shares.

According to analysts, 908 Devices's stock has a predicted upside of 189.86% based on their 12-month stock forecasts.

Over the previous 90 days, 908 Devices's stock had 1 downgrade by analysts.

908 Devices has been rated by research analysts at Leerink Partners, Leerink Partnrs, and Stifel Nicolaus in the past 90 days.

Analysts like 908 Devices less than other "medical" companies. The consensus rating score for 908 Devices is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how MASS compares to other companies.


This page (NASDAQ:MASS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners